Medicines for Malaria Venture (MMV)
@mmv.org
A leading global health partnership working to reduce the burden of malaria. We discover, develop and deliver new antimalarial medicines.
#Malaria is often seen as inevitable, but it doesn’t have to be. Phase 3 results for GanLum, developed by Novartis & MMV, could further expand the antimalarial toolbox. But funding & political will remain the biggest barriers to access and #innovation 👉 bit.ly/3MIZabP
The end of malaria
How politics, not parasites, became the biggest threat in the fight against malaria
bit.ly
December 19, 2025 at 2:11 PM
#Malaria is often seen as inevitable, but it doesn’t have to be. Phase 3 results for GanLum, developed by Novartis & MMV, could further expand the antimalarial toolbox. But funding & political will remain the biggest barriers to access and #innovation 👉 bit.ly/3MIZabP
Scenes from last week’s co-creation workshop in Accra, where MMV & @deepmirror.bsky.social convened a group of Africa-based researchers convened to learn about & shape the continued development of the AI-powered Drug Discovery for Global Health platform. More 👉 bit.ly/4qeyz55
December 19, 2025 at 2:09 PM
Scenes from last week’s co-creation workshop in Accra, where MMV & @deepmirror.bsky.social convened a group of Africa-based researchers convened to learn about & shape the continued development of the AI-powered Drug Discovery for Global Health platform. More 👉 bit.ly/4qeyz55
Children’s medicines lag nearly a decade behind adult treatments.
@who.int’s GAP-f network is working to close this gap. Its recent #malaria PADO exercise – supported by MMV – set a research agenda to better address children’s needs.
Report 👉 bit.ly/4pyfMBN
@who.int’s GAP-f network is working to close this gap. Its recent #malaria PADO exercise – supported by MMV – set a research agenda to better address children’s needs.
Report 👉 bit.ly/4pyfMBN
December 19, 2025 at 1:20 PM
Children’s medicines lag nearly a decade behind adult treatments.
@who.int’s GAP-f network is working to close this gap. Its recent #malaria PADO exercise – supported by MMV – set a research agenda to better address children’s needs.
Report 👉 bit.ly/4pyfMBN
@who.int’s GAP-f network is working to close this gap. Its recent #malaria PADO exercise – supported by MMV – set a research agenda to better address children’s needs.
Report 👉 bit.ly/4pyfMBN
This year proved we can regain momentum against #malaria. To defeat it, we need broader access and new #innovations. MMV's CEO Martin Fitchet shares what’s needed in 2026 to accelerate progress through innovation & partnership.
December 19, 2025 at 12:21 PM
This year proved we can regain momentum against #malaria. To defeat it, we need broader access and new #innovations. MMV's CEO Martin Fitchet shares what’s needed in 2026 to accelerate progress through innovation & partnership.
The @gatesfoundation.bsky.social Goalkeepers Report warns child deaths are rising for the first time this century. Shrinking global health funding puts millions more at risk. For #malaria, the message is urgent: strengthen prevention, treatment & equitable access 👉 bit.ly/48rzNEc
2025 Goalkeepers Report | Ending Preventable Child Deaths with Primary Healthcare, Vaccines, and Next-Gen Innovations
Millions of children’s lives are at stake—without action, global aid cuts could lead to more child deaths over the next 20 years. But that future isn’t inevitable. If we act now—by getting proven, low...
bit.ly
December 19, 2025 at 11:59 AM
The @gatesfoundation.bsky.social Goalkeepers Report warns child deaths are rising for the first time this century. Shrinking global health funding puts millions more at risk. For #malaria, the message is urgent: strengthen prevention, treatment & equitable access 👉 bit.ly/48rzNEc
A powerful trio of #malaria prevention tools – vector control, chemoprevention & vaccines – helped protect millions last year.
MMV works with national malaria control programmes & African manufacturers to continue expanding access to SMC for children and pregnant women.
MMV works with national malaria control programmes & African manufacturers to continue expanding access to SMC for children and pregnant women.
December 18, 2025 at 1:51 PM
A powerful trio of #malaria prevention tools – vector control, chemoprevention & vaccines – helped protect millions last year.
MMV works with national malaria control programmes & African manufacturers to continue expanding access to SMC for children and pregnant women.
MMV works with national malaria control programmes & African manufacturers to continue expanding access to SMC for children and pregnant women.
The #WorldMalariaReport is clear: drug resistance is advancing. Our response must be just as clear: new meds with new mechanisms of action.
Collaboration, commitment & funding can keep us ahead of resistance & help deliver next-gen meds to ensure #malaria is no longer a threat.
Collaboration, commitment & funding can keep us ahead of resistance & help deliver next-gen meds to ensure #malaria is no longer a threat.
December 18, 2025 at 1:49 PM
The #WorldMalariaReport is clear: drug resistance is advancing. Our response must be just as clear: new meds with new mechanisms of action.
Collaboration, commitment & funding can keep us ahead of resistance & help deliver next-gen meds to ensure #malaria is no longer a threat.
Collaboration, commitment & funding can keep us ahead of resistance & help deliver next-gen meds to ensure #malaria is no longer a threat.
On 18 January, graduate researcher Camille Gourjault is taking the fight against #malaria from the lab to the streets, running the Hong Kong Marathon in support of MMV’s mission to develop and deliver the next generation of antimalarials. Learn more 👉 bit.ly/3KMhT5K
Running Hong Kong marathon to fight Malaria with MMV
Help Camille Gourjault raise money to support MMV Medicines for Malaria Venture
bit.ly
December 17, 2025 at 12:48 PM
On 18 January, graduate researcher Camille Gourjault is taking the fight against #malaria from the lab to the streets, running the Hong Kong Marathon in support of MMV’s mission to develop and deliver the next generation of antimalarials. Learn more 👉 bit.ly/3KMhT5K
Antimalarial drug resistance won’t wait, and neither should we. At the #WorldMalariaReport launch in the UK Parliament, MMV’s Cristina Donini highlighted our efforts to stay one step ahead of resistance and the role UK science & innovation play in the fight against #malaria.
December 16, 2025 at 1:55 PM
Antimalarial drug resistance won’t wait, and neither should we. At the #WorldMalariaReport launch in the UK Parliament, MMV’s Cristina Donini highlighted our efforts to stay one step ahead of resistance and the role UK science & innovation play in the fight against #malaria.
Can AI advance #malaria elimination & support an inclusive global health system? In @devex.com, MMV experts highlight 3 opportunities:
• Faster next-gen drug discovery
• Co-creating innovation with endemic-country researchers
• Turning complex data into actionable insights
More 👉 bit.ly/3Mxkilk
• Faster next-gen drug discovery
• Co-creating innovation with endemic-country researchers
• Turning complex data into actionable insights
More 👉 bit.ly/3Mxkilk
3 ways AI can support drug innovation and global research equity
Opinion: Artificial intelligence could be a crucial multiplier in the fight against malaria. Researchers from Medicines for Malaria Venture explore how to harness its power while ensuring endemic-coun...
bit.ly
December 10, 2025 at 9:48 AM
Can AI advance #malaria elimination & support an inclusive global health system? In @devex.com, MMV experts highlight 3 opportunities:
• Faster next-gen drug discovery
• Co-creating innovation with endemic-country researchers
• Turning complex data into actionable insights
More 👉 bit.ly/3Mxkilk
• Faster next-gen drug discovery
• Co-creating innovation with endemic-country researchers
• Turning complex data into actionable insights
More 👉 bit.ly/3Mxkilk
Quality-assured antimalarials made locally are vital to reducing the #malaria burden in Africa.
With MMV support, Swipha Nigeria’s SP has achieved @who.int prequalification, and the US Gov has procured 5M doses, protecting +1.6M pregnant women in Nigeria.
More 👉 bit.ly/3MhXUfT
With MMV support, Swipha Nigeria’s SP has achieved @who.int prequalification, and the US Gov has procured 5M doses, protecting +1.6M pregnant women in Nigeria.
More 👉 bit.ly/3MhXUfT
First procurement of a preventive antimalarial from Swipha, a Nigerian manufacturer | Medicines for Malaria Venture
MMV’s technical support helps Swipha deliver malaria medicines to pregnant Nigerian women
bit.ly
December 9, 2025 at 11:57 AM
Quality-assured antimalarials made locally are vital to reducing the #malaria burden in Africa.
With MMV support, Swipha Nigeria’s SP has achieved @who.int prequalification, and the US Gov has procured 5M doses, protecting +1.6M pregnant women in Nigeria.
More 👉 bit.ly/3MhXUfT
With MMV support, Swipha Nigeria’s SP has achieved @who.int prequalification, and the US Gov has procured 5M doses, protecting +1.6M pregnant women in Nigeria.
More 👉 bit.ly/3MhXUfT
Cabo Verde went from #malaria once being the leading cause of death to earning @who.int certification as malaria-free in 2024. A new @gatesfoundation.bsky.social article highlights key lessons: political will, collaboration, smart investment & strong health systems 👉 bit.ly/4pI2tOV
What can the world learn from Cabo Verde’s fight against malaria?
Cabo Verde’s decades-long effort to eliminate malaria shows how persistence, partnership, and local leadership can create a model for global health progress.
bit.ly
December 5, 2025 at 10:29 AM
Cabo Verde went from #malaria once being the leading cause of death to earning @who.int certification as malaria-free in 2024. A new @gatesfoundation.bsky.social article highlights key lessons: political will, collaboration, smart investment & strong health systems 👉 bit.ly/4pI2tOV
The @who.int 2025 World malaria report brings a clear message: drug resistance threatens to undo hard-won gains against #malaria. With progress stalling, we must double down on innovation, surveillance and long-term commitment to stay ahead of resistance 👉 bit.ly/48JynVs
December 4, 2025 at 9:30 AM
The @who.int 2025 World malaria report brings a clear message: drug resistance threatens to undo hard-won gains against #malaria. With progress stalling, we must double down on innovation, surveillance and long-term commitment to stay ahead of resistance 👉 bit.ly/48JynVs
On International Day of Persons with Disabilities. MMV is proud to be part of the @who.int Disability Health Equity Network. The relationships built through the network will help us define what disability inclusion means for MMV. #IDPD #DisabilityDay #Malaria #GlobalHealth
December 3, 2025 at 8:42 AM
On International Day of Persons with Disabilities. MMV is proud to be part of the @who.int Disability Health Equity Network. The relationships built through the network will help us define what disability inclusion means for MMV. #IDPD #DisabilityDay #Malaria #GlobalHealth
#ClimateChange is expanding #malaria-risk zones across Africa, a new Global Change Biology study warns, potentially putting millions more at risk. We need innovative, accessible tools to stay ahead 👉 bit.ly/4iyhTTu
December 2, 2025 at 11:14 AM
#ClimateChange is expanding #malaria-risk zones across Africa, a new Global Change Biology study warns, potentially putting millions more at risk. We need innovative, accessible tools to stay ahead 👉 bit.ly/4iyhTTu
Can AI help democratize the global fight against #malaria? In
@healthpolicywatch.bsky.social, MMV’s Jeremy Burrows explains how AI could speed up drug discovery and how a new platform with @deepmirror.bsky.social aims to make these tools more accessible worldwide.
Read: bit.ly/4aj84GU
@healthpolicywatch.bsky.social, MMV’s Jeremy Burrows explains how AI could speed up drug discovery and how a new platform with @deepmirror.bsky.social aims to make these tools more accessible worldwide.
Read: bit.ly/4aj84GU
Interview: Can AI democratize the global fight against malaria? | Medicines for Malaria Venture
An interview with MMV's Head of Drug Discovery on how artificial intelligence could compress years of drug discovery into months - helping to overcome growing drug resistance to existing treatments fo...
bit.ly
December 1, 2025 at 2:52 PM
Can AI help democratize the global fight against #malaria? In
@healthpolicywatch.bsky.social, MMV’s Jeremy Burrows explains how AI could speed up drug discovery and how a new platform with @deepmirror.bsky.social aims to make these tools more accessible worldwide.
Read: bit.ly/4aj84GU
@healthpolicywatch.bsky.social, MMV’s Jeremy Burrows explains how AI could speed up drug discovery and how a new platform with @deepmirror.bsky.social aims to make these tools more accessible worldwide.
Read: bit.ly/4aj84GU
How do #malaria parasites survive in the mosquito gut?
Researchers have profiled gene activity to find out, revealing insights that could inform new transmission-blocking tools.
Read more in @nature.com: bit.ly/3XeaP4B
Researchers have profiled gene activity to find out, revealing insights that could inform new transmission-blocking tools.
Read more in @nature.com: bit.ly/3XeaP4B
November 28, 2025 at 3:27 PM
How do #malaria parasites survive in the mosquito gut?
Researchers have profiled gene activity to find out, revealing insights that could inform new transmission-blocking tools.
Read more in @nature.com: bit.ly/3XeaP4B
Researchers have profiled gene activity to find out, revealing insights that could inform new transmission-blocking tools.
Read more in @nature.com: bit.ly/3XeaP4B
Press release 📢 Announcing MMV's new partnership with South Korean biotechnology leader Shaperon to advance game-changing, nanobody treatments for #malaria prevention.
🎥 Watch the video to learn how nanobody technology can change the game for #GlobalHealth.
🎥 Watch the video to learn how nanobody technology can change the game for #GlobalHealth.
November 27, 2025 at 1:08 PM
Press release 📢 Announcing MMV's new partnership with South Korean biotechnology leader Shaperon to advance game-changing, nanobody treatments for #malaria prevention.
🎥 Watch the video to learn how nanobody technology can change the game for #GlobalHealth.
🎥 Watch the video to learn how nanobody technology can change the game for #GlobalHealth.
Vivax #malaria relapses keep patients trapped in a cycle. The Partnership for Vivax Elimination (PAVE) has been generating evidence from across endemic countries to support country elimination goals.
November 27, 2025 at 11:27 AM
Vivax #malaria relapses keep patients trapped in a cycle. The Partnership for Vivax Elimination (PAVE) has been generating evidence from across endemic countries to support country elimination goals.
Is #malaria eradication still within reach?
Experts at #ASTMH25, convened by @gatesfoundation.bsky.social & MMV for a sponsored symposium, say yes...with next-gen tools, strong endemic-country leadership & sustained investment.
🎥 Watch it here: bit.ly/4inePJY
Experts at #ASTMH25, convened by @gatesfoundation.bsky.social & MMV for a sponsored symposium, say yes...with next-gen tools, strong endemic-country leadership & sustained investment.
🎥 Watch it here: bit.ly/4inePJY
November 26, 2025 at 12:53 PM
Is #malaria eradication still within reach?
Experts at #ASTMH25, convened by @gatesfoundation.bsky.social & MMV for a sponsored symposium, say yes...with next-gen tools, strong endemic-country leadership & sustained investment.
🎥 Watch it here: bit.ly/4inePJY
Experts at #ASTMH25, convened by @gatesfoundation.bsky.social & MMV for a sponsored symposium, say yes...with next-gen tools, strong endemic-country leadership & sustained investment.
🎥 Watch it here: bit.ly/4inePJY
@globalhealthedctp3.bsky.social builds and fosters Africa–Europe research partnerships transforming innovative science into global health impact, including the consortium behind Coartem Baby, the first #malaria treatment for infants 2 to <5 kg.
Read more: bit.ly/4ii8b7w
Read more: bit.ly/4ii8b7w
EDCTP: Two decades of Africa-Europe partnership delivering excellent science and life-saving innovations
Despite remarkable progress in global health, the world faces new threats, from re-emerging infections and pandemics to antimicrobial resistance and climate-related health impacts. Amid growing geopol...
bit.ly
November 26, 2025 at 11:12 AM
@globalhealthedctp3.bsky.social builds and fosters Africa–Europe research partnerships transforming innovative science into global health impact, including the consortium behind Coartem Baby, the first #malaria treatment for infants 2 to <5 kg.
Read more: bit.ly/4ii8b7w
Read more: bit.ly/4ii8b7w
Paul Boateng (Ghana NMEP) on staying ahead of antimalarial drug resistance, including the use of MFT to reduce pressure on ACTs. Through the ALARM partnership, MMV & Ghana's NMEP are conducting an MFT pilot following similar successful pilots in Kenya & Burkina Faso. #WAAW25
November 24, 2025 at 9:36 PM
Paul Boateng (Ghana NMEP) on staying ahead of antimalarial drug resistance, including the use of MFT to reduce pressure on ACTs. Through the ALARM partnership, MMV & Ghana's NMEP are conducting an MFT pilot following similar successful pilots in Kenya & Burkina Faso. #WAAW25
At #CPHIA2025, Dr Edwin Onyango from Kenya’s NMCP explained partial-artemisinin resistance.
MMV & partners are developing a triple ACT, combining artemether-lumefantrine with amodiaquine. This medicine is now in Phase 3 clinical trials.
#WAAW25
MMV & partners are developing a triple ACT, combining artemether-lumefantrine with amodiaquine. This medicine is now in Phase 3 clinical trials.
#WAAW25
November 24, 2025 at 4:21 PM
At #CPHIA2025, Dr Edwin Onyango from Kenya’s NMCP explained partial-artemisinin resistance.
MMV & partners are developing a triple ACT, combining artemether-lumefantrine with amodiaquine. This medicine is now in Phase 3 clinical trials.
#WAAW25
MMV & partners are developing a triple ACT, combining artemether-lumefantrine with amodiaquine. This medicine is now in Phase 3 clinical trials.
#WAAW25
How can collaboration, bold science & sustained funding help tackle antimalarial drug resistance?
MMV's Cristina Donini shares how resistance threatens the #malaria agenda & discusses our strategy to stay ahead of it.
Read more via Mediaplanet: bit.ly/4p9F9Jw
#WAAW25
MMV's Cristina Donini shares how resistance threatens the #malaria agenda & discusses our strategy to stay ahead of it.
Read more via Mediaplanet: bit.ly/4p9F9Jw
#WAAW25
A race against time: antimalarial drug resistance | Medicines for Malaria Venture
Cristina Donini, Head of Research and Early Development, MMV, shares her concerns around antimalarial drug resistance (AMDR) and outlines innovative strategies to advance malaria care and protect vuln...
bit.ly
November 24, 2025 at 4:15 PM
How can collaboration, bold science & sustained funding help tackle antimalarial drug resistance?
MMV's Cristina Donini shares how resistance threatens the #malaria agenda & discusses our strategy to stay ahead of it.
Read more via Mediaplanet: bit.ly/4p9F9Jw
#WAAW25
MMV's Cristina Donini shares how resistance threatens the #malaria agenda & discusses our strategy to stay ahead of it.
Read more via Mediaplanet: bit.ly/4p9F9Jw
#WAAW25
Drug resistance threatens #malaria elimination and global health security. Researchers across endemic countries, Japan and Europe are working together to develop new innovations and ensure communities can access effective, affordable tools.
More here: bit.ly/3X67ogi
More here: bit.ly/3X67ogi
Exploring New Frontiers In The Fight Against Malaria - Health Policy Watch
This week, the world marks World Antimicrobial Awareness Week and malaria parasites, though often forgotten, are part of the range of microbes preventing us
bit.ly
November 23, 2025 at 2:24 PM
Drug resistance threatens #malaria elimination and global health security. Researchers across endemic countries, Japan and Europe are working together to develop new innovations and ensure communities can access effective, affordable tools.
More here: bit.ly/3X67ogi
More here: bit.ly/3X67ogi